LUM
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Vertex Pharmaceuticals Incorporated
Overview
LUM is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
LUM clinical trials
Explore related
Medical disclaimer. This page summarizes research about LUM for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.